PATENT CLAIM ANALYSIS

Application Number: 15895220
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "054000"]

Abstract:
Compositions and methods for the surface appearance of the skin a subject are provided. An injectable composition comprising at least hyaluronic acid or a salt thereof; and an effective amount of at least mepivacaine or a salt thereof are provided. The hyaluronic acid optionally has an average molecular weight ranging from 50,000 to 10,000,000 Daltons, and may be crosslinked hyaluronic acids, non-crosslinked hyaluronic acids, or a combination, in some embodiments. The compositions and methods of the present invention are useful for treating and preventing the cutaneous signs of chronological aging and/or induced by external factors such as stress, air pollution, tobacco or prolonged exposure to ultraviolet (UV) exposure, impaired surface appearance of the skin, impaired viscoelastic or biomechanical properties of the skin, and/or the long-lasting filling of volume defects of the skin.

Claim (Index 14):
The stable, sterile, injectable composition of  claim 11 , wherein the hyaluronic acid or salt thereof comprises hyaluronic acid crosslinked with 1,4-butanediol diglycidyl ether (BDDE).

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.70115
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15705809', '12393884', '15044236', '13653266', '15214983']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8093309021336699
- 35 USC 102 Novelty (BERT): 0.5683532033895752
- Combined Prediction Score: 0.7852331322592605
- Mean Citation Score: 379.986592
- Max Citation Score: 473.2397
- Similarity Product: 367.3282021535814

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test